Invivyd Inc
For the period ended Mar 31, 2024. Filed May 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 9, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations and Comprehensive Loss
(UNaudited)
(In thousands, except share and per share amounts)
| Three Months Ended March 31, | Three Months Ended March 31, | |
|---|---|---|
| 2024 | 2023 | |
| Operating expenses: | ||
| Research and development(1) | $31,160 | $27,201 |
| Acquired in-process research and development(2) | — | 825 |
| Selling, general and administrative | 14,929 | 11,045 |
| Total operating expenses | 46,089 | 39,071 |
| Loss from operations | (46,089) | (39,071) |
| Other income: | ||
| Other income, net | 2,593 | 3,750 |
| Total other income, net | 2,593 | 3,750 |
| Net loss | (43,496) | (35,321) |
| Other comprehensive income (loss) | ||
| Unrealized gain on available-for-sale securities, net of tax | 1 | 157 |
| Comprehensive loss | $(43,495) | $(35,164) |
| Net loss per share attributable to common stockholders, basic and diluted | $(0.38) | $(0.32) |
| Weighted-average common shares outstanding, basic and diluted | 115,618,209 | 108,785,519 |
(1)
Includes related-party amounts of $1,135 and $2,960 for thethree months ended March 31, 2024 and 2023, respectively(see Note 14).
(2)
Includes related-party amounts of $0 and $375 for thethree months ended March 31, 2024 and 2023, respectively (see Note 14).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.